Troponin I Peptide 3 Antibody

Product Description

Troponin I Peptide 3 Antibody
Catalog number: B2011324
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 0.1 mg
Molecular Weight or Concentration: 4-6 mg/mL
Supplied as: Solution
Applications: molecular tool for various biochemical applications
Storage: 2-8 °C
Keywords: anti-Troponin I
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: O’Donohoe TJ, Ketheesan N, Schrale RG. Anti-troponin antibodies following myocardial infarction J Cardiol. 2017 Jan;69(1):38-45.
2: Nussinovitch U, Shoenfeld Y. Anti-troponin autoantibodies and the cardiovascular system Heart. 2010 Oct;96(19):1518-24.
3: Erer HB, Güvenç TS, Kemik AS, Yılmaz HY, Kul Ş, Altay S, Sayar N, Kaya Y, Eren M. Troponin and anti-troponin autoantibody levels in patients with ventricular noncompaction PLoS One. 2013;8(2):e57648.
4: Nunes JP, Sampaio S, Cerqueira A, Kaya Z, Oliveira NP. Anti-troponin I antibodies in renal transplant patients Rev Port Cardiol. 2015 Feb;34(2):85-9.
5: Çimen D, Bereli N, Günaydın S, Denizli A. Detection of cardiac troponin-I by optic biosensors with immobilized anti-cardiac troponin-I monoclonal antibody Talanta. 2020 Nov 1;219:121259.
6: Pollack CV, Amin A, Wang T, Deitelzweig S, Cohen M, Slattery D, Fanikos J, DiLascia C, Tuder R, Kaatz S. Contemporary NSTEMI management: the role of the hospitalist Hosp Pract (1995). 2020 Feb;48(1):1-11.
7: Rebeiz AG, Mahfoud Z, Abdul Fattah M, Saad A, Safar A, Bashshur ZF. Change in cardiac troponin T level after intravitreal anti-vascular endothelial growth factor treatment: Prospective pilot study Eur J Ophthalmol. 2020 May;30(3):563-569.
8: Gélinas R, Mailleux F, Dontaine J, Bultot L, Demeulder B, Ginion A, Daskalopoulos EP, Esfahani H, Dubois-Deruy E, Lauzier B, Gauthier C, Olson AK, Bouchard B, Des Rosiers C, Viollet B, Sakamoto K, Balligand JL, Vanoverschelde JL, Beauloye C, Horman S, Bertrand L. AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation Nat Commun. 2018 Jan 25;9(1):374.
9: McNamara N, Ibrahim A, Satti Z, Ibrahim M, Kiernan TJ. Acute pericarditis: a review of current diagnostic and management guidelines Future Cardiol. 2019 Mar;15(2):119-126.
10: Scard C, Nguyen JM, Varey E, Moustaghfir I, Khammari A, Dreno B. Cardiac adverse events associated with anti-PD-1 therapy in patients treated for advanced melanoma: relevance of dosing troponin T levels Eur J Dermatol. 2021 Apr 1;31(2):205-212.

Products Related to Troponin I Peptide 3 Antibody can be found at Antibodies